Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,75 USD | +4,17% | -4,89% | -13,37% |
Vakgebied
Aantal werknemers: 89
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Proprietary Therapeutics
100,0
%
| 15 | 100,0 % | 24 | 100,0 % | +60,06% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 24 | 100,0 % | +60,06% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Lennon
CEO | Chief Executive Officer | 53 | 02-10-23 |
Scott Giacobello
DFI | Director of Finance/CFO | 54 | 28-11-21 |
Neil Desai
CHM | Chairman | 59 | 01-10-11 |
Berta Grigorian
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Loretta Itri
CTO | Chief Tech/Sci/R&D Officer | 74 | 25-10-21 |
Marcy Graham
IRC | Investor Relations Contact | 57 | 01-05-22 |
Raymond Steitz
HRO | Human Resources Officer | - | 01-06-22 |
Andrew Kwon
PRN | Corporate Officer/Principal | - | 01-01-19 |
Bryan Ball
PRN | Corporate Officer/Principal | 54 | 01-08-22 |
Stephen M. Rodin
LAW | General Counsel | 47 | 01-02-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anupam Dalal
BRD | Director/Board Member | 52 | 26-08-21 |
Caley Castelein
CHM | Chairman | 53 | 26-08-21 |
Director/Board Member | 52 | 26-08-21 | |
Director/Board Member | 69 | 26-08-21 | |
Emma Reeve
BRD | Director/Board Member | 63 | 08-09-21 |
Mohammad Hirmand
BRD | Director/Board Member | 54 | 27-03-23 |
Neil Desai
CHM | Chairman | 59 | 01-10-11 |
Behzad Aghazadeh
BRD | Director/Board Member | 52 | 26-08-21 |
David Lennon
CEO | Chief Executive Officer | 53 | 02-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 24 554 205 | 19 866 312 ( 80,91 %) | 0 | 80,91 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,37% | 42,97 mln. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,35 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |
- Beurs
- Aandelen
- Koers AADI
- Onderneming Aadi Bioscience, Inc.